Table: Zeria Pharm -2015/16 parent results
May 13 (Reuters)-
Zeria Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 48.27 48.87
(-1.2 pct) (-6.2 pct)
Operating 1.39 587 mln
(+136.3 pct) (-86.6 pct)
Recurring 2.59 1.73
(+49.4 pct) (-67.0 pct)
Net 2.60 2.29
(+13.4 pct) (-46.0 pct)
EPS 48.93 yen 43.16 yen
Ann Div 31.00 yen 30.00 yen 32.00 yen
-Q2 Div 15.00 yen 15.00 yen 16.00 yen
-Q4 Div 16.00 yen 15.00 yen 16.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))